Patents/Inventors

Michael Heartlein

Cambridge, MAUS57 patents

53 Patents

US125942452026
Dry Powder Formulations for Messenger RNA
Translate Bio, Inc.
0 cites
US125942952026
CFTR Mrna Compositions and Related Methods and Uses
ETHRIS GmbH
0 cites
US125775542026
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US125776002026
Modification of Rna-related Enzymes for Enhanced Production
TRANSLATE BIO, Inc.
0 cites
US125695722026
Messenger RNA Therapy for the Treatment of Friedreich's Ataxia
TRANSLATE BIO, Inc.
0 cites
US125646452026
Methods for Treatment of Methylmalonic Acidemia
TRANSLATE BIO, Inc.
0 cites
US125528582026
Methods and Compositions for Delivering Mrna Coded Antibodies
TRANSLATE BIO, Inc.
0 cites
US125334022026
MRNA Therapy for Argininosuccinate Synthetase Deficiency
TRANSLATE BIO, Inc.
0 cites
US125096662025
MRNA Therapy for Phenylketonuria
TRANSLATE BIO, Inc.
0 cites
US124598852025
Ionizable Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US124537392025
Synergistic Enhancement of the Delivery of Nucleic Acids via Blended Formulations
TRANSLATE BIO, Inc.
0 cites
US124215382025
Quantitative Assessment for Cap Efficiency of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US124104222025
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US123770532025
Cationic Polymers
TRANSLATE BIO, Inc.
0 cites
US123702382025
Composition and Methods for Treatment of Primary Ciliary Dyskinesia
TRANSLATE BIO, Inc.
0 cites
US123702622025
Messenger RNA Vaccines and Uses Thereof
Translate Bio, Inc.
0 cites
US123310052025
Ionizable Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US122801172025
Lipid Nanoparticle Formulations for Delivery of MRNA
TRANSLATE BIO, Inc.
0 cites
US122801472025
PEG Lipidoid Compounds
TRANSLATE BIO, Inc.
0 cites
US122687542025
Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency
TRANSLATE BIO, Inc.
0 cites
US122470462025
Ribonucleic Acids with 4′-thio-modified Nucleotides and Related Methods
Translate Bio, Inc.
0 cites
US122408242025
Vitamin Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US122344462025
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US122016772025
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency
TRANSLATE BIO, Inc.
0 cites
US121955052025
Treatment of Cystic Fibrosis by Delivery of Nebulized Mrna Encoding CFTR
TRANSLATE BIO, Inc.
0 cites
US121448712024
Stable Compositions of Mrna-loaded Lipid Nanoparticles and Processes of Making
TRANSLATE BIO, Inc.
0 cites
US121215922024
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Translate Bio, Inc.
0 cites
US121027202024
Cleavable Lipids
Translate Bio, Inc.
0 cites
US120847022024
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US120847112024
Quantitative Assessment for Cap Efficiency of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US120764392024
Thioester Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US120645152024
Process of Preparing Mrna-loaded Lipid Nanoparticles
TRANSLATE BIO, Inc.
0 cites
US120603812024
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US120169542024
CNS Delivery of Mrna and Uses Thereof
TRANSLATE BIO, Inc.
0 cites
US119986012024
Messenger RNA Therapy for Treatment of Articular Disease
TRANSLATE BIO, Inc.
0 cites
US119996752024
Ionizable Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US119751102024
Cationic Polymers
TRANSLATE BIO, Inc.
0 cites
US119762722024
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US119640512024
Ribose Cationic Lipids
TRANSLATE BIO, Inc.
0 cites
US119511792024
Lipid Nanoparticle Compositions and Methods for MRNA Delivery
Translate Bio, Inc.
0 cites
US119511802024
Lipid Nanoparticle Compositions and Methods for MRNA Delivery
Translate Bio, Inc.
0 cites
US119511812024
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
Translate Bio, Inc.
0 cites
US119201822024
Quantitative Assessment for Cap Efficiency of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US118903772024
Lipid Formulations for Delivery of Messenger RNA
Massachusetts Institute Of Technology
0 cites
US118846922024
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US118209772023
Methods for Purification of Messenger RNA
TRANSLATE BIO, Inc.
0 cites
US117308252023
Lipid Nanoparticle Compositions and Methods for Mrna Delivery
TRANSLATE BIO, Inc.
0 cites
US117124632023
MRNA Therapy for Pompe Disease
Translate Bio, Inc.
0 cites
US116921892023
Methods for Purification of Messenger RNA
Translate Bio, Inc.
0 cites
US115595612023
Composition and Methods for Treatment of Primary Ciliary Dyskinesia
TRANSLATE BIO, Inc.
0 cites
US115605622023
Large-scale Synthesis of Messenger RNA
Translate Bio, Inc.
0 cites
US115476662023
Cationic Lipids Comprising a Steroidal Moiety
Translate Bio, Inc.
0 cites
US115477642023
Lipid Nanoparticle Compositions and Methods for MRNA Delivery
TRANSLATE BIO, Inc.
0 cites